Preclinical Assessment of Safety and Efficacy of Deferoxamine (DFO)-pretreated Feline Adipose Mesenchymal Stem Cells
Utilizing a mouse model of acute lung injury, we demonstrated the potential of DFO-pretreated fATMSCs as a safe and effective therapeutic approach for inflammatory disorders.
Authors
- Yanheng Zhou (ORCID: https://orcid.org/0000-0002-5610-9967)
- Hyun‐A Seong (ORCID: https://orcid.org/0000-0002-5997-9028)
- Shing Wan Choi (ORCID: https://orcid.org/0000-0003-2215-3238)
- Sijia Jin (ORCID: https://orcid.org/0009-0007-6893-2946)
- Min‐Kyung Cho (ORCID: https://orcid.org/0000-0003-2090-4448)
- X. Li (ORCID: https://orcid.org/0000-0002-5914-5736)
- Mei‐Fu Xuan (ORCID: https://orcid.org/0009-0004-8566-4996)
- Xingrui Ji (ORCID: https://orcid.org/0009-0003-0500-8132)
- Qiang Li (ORCID: https://orcid.org/0000-0002-8388-0968)
- Zhiqiang Ma (ORCID: https://orcid.org/0000-0002-1982-323X)
- Haibo Teng (ORCID: https://orcid.org/0009-0007-7066-5779)
Institutions
- Chungbuk National University (KR)
- Yanbian University (CN)
Publication Details
- Journal
- In Vivo
- Published
- 2024-12-31
- DOI
- https://doi.org/10.21873/invivo.13825
- Citations
- 1
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.44
Funders
- National Research Foundation
- National Research Foundation of Korea
- People's Government of Jilin Province
- Ministry of Education, India